Table 2. Comparison of recent series with hepatopancreatoduodenectomy (only cholangiocarcinoma, i.e., gall bladder carcinoma is excluded).
| Author | Year | n cases | Maj. Hepat. [%] | R0 [%] | Morbidity [%] | Mortality [%] | 5-year survival |
|---|---|---|---|---|---|---|---|
| Hirono (230) | 2006 | 6 | 100 | – | 100 | 16.7 | – |
| Miwa (231) | 2007 | 14 | 85.7 | 78.6 | 30.8* | 0 | 51.9 |
| Wakai (232) | 2008 | 17 | 100 | 58.8 | 82* | 29.4 | 11.8 |
| Kaneoka (233) | 2010 | 14 | 92.9 | 64.3 | 57.1 | 0 | 50 |
| Hemming (234) | 2010 | 13 | – | – | 35* | 0 | 24 |
| Ebata (235) | 2012 | 85 | 92.9 | 72.9 | 77.6 | 2.4 | 37.4 |
| Lim (236) | 2012 | 13 | 100 | 54.5 | 91* | 0 | 32.3 |
| Sakamoto (237) | 2013 | 14 | 100 | 57.1 | 95* | 0 | 53 |
*, including different tumor entities.